If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSO4.L Regulatory News (SO4)

  • There is currently no data for SO4

Funds from First Drawdown Received

22 Dec 2020 07:36

RNS Number : 4943J
Salt Lake Potash Limited
22 December 2020
 

22 December 2020

 

AIM/ASX Code: SO4

 

 

SALT LAKE POTASH LIMITED

 

First Drawdown of US$105m under the SFA Received

Salt Lake Potash Limited (SO4 or the Company) is pleased to announce that it has satisfied all remaining conditions precedents under the Syndicated Facility Agreement (SFA) to achieve financial close and has received debt funds from the first drawdown of US$105 million.

Debt Financial Close and First Draw

· As announced on 5 August 2020, the Company has executed the US$138m Syndicated Facility Agreement with Taurus Mining Finance Fund No.2 L.P and the Clean Energy Finance Corporation.

· Following completion of Tranche 1 of the Placement to raise A$50m (before costs) on 18 December 2020, the Company has satisfied all remaining conditions precedents under the SFA to achieve financial close.

· Funds representing the first US$105m tranche have been received enabling repayment of the US$45m Bridge Facility and to further the completion of project construction.

TONY SWIERICZUK, Chief Executive Officer

"SO4 is very pleased to have achieved financial close on the US$138m Taurus/CEFC debt facility and to have drawn down the initial tranche of US$105m. This is a substantial milestone in the development of the Company and the Lake Way Project. Drawdown has facilitated the repayment of the Bridge facility which enabled SO4 to progress the project substantially since August 2019. In combination with the recent Placement, these funds will ensure the Company is well financed to deliver the Lake Way Project."

For further information please visit www.so4.com.au or contact:

 

Tony Swiericzuk / Richard Knights

Salt Lake Potash Limited

Tel: +61 8 6559 5800

Colin Aaronson / Seamus Fricker

Grant Thornton UK LLP (Nominated Adviser)

Tel: +44 (0) 20 7383 5100

Derrick Lee / Peter Lynch

Cenkos Securities plc (Joint Broker)

Tel: +44 (0) 131 220 6939

Rupert Fane / Ernest Bell

Hannam & Partners (Joint Broker)

Tel: +44 (0) 20 7907 8500

 

This announcement has been authorised for release by the Managing Director, Mr Tony Swiericzuk.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Forward Looking Statements

This announcement includes forward-looking statements. These forward-looking statements are based on the Company's expectations and beliefs concerning future events. Forward-looking statements are necessarily subject to risks, uncertainties and other factors, many of which are outside the control of the Company, which could cause actual results to differ materially from such statements. Although the Company believes that its forward-looking statements have reasonable grounds, can give no assurance that they will be achieved. They may be affected by a variety of variables and changes in underlying assumptions that are subject to risk factors associated with the nature of the Company's business (including those described in pages 25 to 29 (inclusive) of the Presentation released to ASX on 11 December 2020), which cause actual results to differ materially from those expressed herein. The Company makes no undertaking to subsequently update or revise the forward-looking statements made in this announcement, save where required by law or regulation, to reflect the circumstances or events after the date of this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDLLBLBLLXFBZ
Date   Source Headline
25th Mar 20217:00 amRNSHolding(s) in Company
22nd Mar 20217:00 amRNSLake Way Process Plant commissioning commences
16th Mar 20217:45 amRNSInterim Results
10th Mar 20217:00 amRNSCompany Presentation - Project Update
4th Mar 20217:00 amRNSSenior debt syndication to Sequoia and CBA
12th Feb 20218:42 amRNSDirector/PDMR Shareholding
11th Feb 20217:06 amRNSCompletion of Placement and Issue of Shares
3rd Feb 20217:00 amRNSIssue of Share Purchase Plan Shares
29th Jan 20217:00 amRNSDecember 2020 Quarterly Report
28th Jan 20217:00 amRNSSO4 Successfully Completes Share Purchase Plan
22nd Jan 20218:58 amRNSResult Of General Meeting
18th Jan 20217:00 amRNSLake Way Project Update. Interim CFO appointed
22nd Dec 20207:36 amRNSFunds from First Drawdown Received
21st Dec 20207:00 amRNSNotice of General Meeting
18th Dec 20209:15 amRNSPlacement, Share Purchase Plan, Securities Issue
11th Dec 20207:00 amRNSFundraising & Lifting of ASX Voluntary Suspension
10th Dec 20207:00 amRNSFunding Update & Short Extension to ASX Suspension
3rd Dec 20207:00 amRNSASX Voluntary Suspension and Funding Update
27th Nov 20203:39 pmRNSFunding Update
27th Nov 20207:00 amRNSASX Trading Halt
20th Nov 20207:00 amRNSResult of AGM
21st Oct 20207:15 amRNSNotice of AGM
19th Oct 20207:00 amRNSOperational and Potash Experience Added to Board
16th Oct 20207:00 amRNSSeptember 2020 Quarterly Report & Issue of Shares
14th Oct 20207:48 amRNSNew Corporate Presentation
12th Oct 20202:05 pmRNSSecond Price Monitoring Extn
12th Oct 20202:00 pmRNSPrice Monitoring Extension
29th Sep 202011:44 amRNSDirector and Other Shareholdings
28th Sep 20207:00 amRNSFinal Results
25th Sep 202011:04 amRNSDate of AGM and Delay to Admission of Shares
23rd Sep 202012:29 pmRNSAGM Statement. Issue of Ordinary Shares
14th Sep 20208:08 amRNSLake Way Project Reaches 60% Completion
3rd Sep 202010:21 amRNSHolding(s) in Company
1st Sep 20207:38 amRNSIssue of Shares - Director/PDMR Shareholding
28th Aug 20207:00 amRNSCompletion Of Retail Entitlement Offer
27th Aug 20207:00 amRNSHolding(s) in Company
24th Aug 20208:08 amRNSNotice of GM
20th Aug 202010:26 amRNSHolding(s) in Company
17th Aug 20207:00 amRNSIssue of Shares and Directors' Subscription
14th Aug 20207:00 amRNSDespatch of Retail Offer Booklet. Loan Conversion
11th Aug 20207:00 amRNSSuccessful Completion of Institutional Offer
6th Aug 20207:00 amRNSEntitlement Offer Amended Timetable for DI Holders
5th Aug 20207:00 amRNSDebt Facility, Equity Raising, Entitlement Offer
31st Jul 20207:00 amRNSJune 2020 Quarterly Report
13th Jul 20207:00 amRNSGreen Label Certification
9th Jul 20207:00 amRNSProcurement Update
3rd Jul 20209:30 amRNSAppendix 3Y Change of Director's Interest Notices
2nd Jul 20207:39 amRNSConvertible Note Placement
23rd Jun 20203:33 pmRNSHolding(s) in Company
17th Jun 20209:03 amRNSResult of Meeting. Completion of Placement.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.